Giving consumers prices so they can shop around for the best value for nonemergency healthcare appears to have only a modest effect on reducing healthcare spending.
Over the last several years a movement to introduce price transparency has emerged in healthcare. However, a new analysis from the Health Care Cost Institute (HCCI) suggests that giving consumers prices so they can shop around for the best value for nonemergency healthcare appears to have only a modest effect on reducing healthcare spending. The institute’s report, “Spending on Shoppable Services in Health Care,” examined 2011 claims data for people under age 65 with employer-sponsored health insurance.
Researchers examined total spending on shoppable healthcare service (those that can be scheduled in advance), such as flu shots, nonemergency hip or knee replacements, colonoscopy, and blood tests. Prescription drugs and devices were not considered in this analysis.
The report found that in 2011:
Although 43% of annual healthcare spending is for services that consumers should shop for based on price, less than 7% of total spending is actually paid out-of-pocket by consumers for shoppable services. Thus, for the vast majority of healthcare spending, providing incentives or information to steer consumer behavior will have limited effects on improving the value of the healthcare dollar, the researchers said.
The HCCI analysis shows that consumers hoping to use price shopping to lower coinsurance and deductibles were able to influence only about 65% of their out-of-pocket payments per year. Price shopping was found to generally have little effect on copayments as they are usually set amounts. Researchers also found that consumers gain little from shopping for many outpatient services; more price variation was found in inpatient than outpatient services. Prices for nonshoppable inpatient services varied more than shoppable ones.
Interestingly, knee and hip replacements, inpatient services often highlighted as being worth shopping for, had less price variation than other services. Variations in pricing for these procedures depended heavily on where one lived.
“There is not much savings to be gained from consumer shopping for many nonemergency services,” HCCI researcher and report coauthor Amanda Frost said in a statement. “While we strongly believe consumers are entitled to price information and to know what they are going to pay prior to any healthcare service, we shouldn’t rely on price transparency as a way to create savvy shoppers to save healthcare dollars.”
More attention should be paid on directly engaging providers and payers, both insurers and employers, because gains from consumer price shopping are limited, she noted.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More